Century Therapeutics Inc (IPSC)

$2.30 +0.01 (0.44%)
Market Cap 200.16M
Revenue (ttm) 109.16M
Net Income (ttm) -9.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -8.78%
Debt to Equity Ratio 0.00
Volume 1,889,500
Avg Vol 1,849,820
Day's Range N/A - N/A
Shares Out 87.41M
Stochastic %K 9%
Beta 1.70
Analysts Strong Sell
Price Target $4.27

Company Profile

Century Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy, under Phase 1 trials targeting CD19 for relapsed and refractory B-cell lymphoma. The company is also involved in the development of CNTY...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 817 5790
Address:
25 North 38th Street, 11th Floor, Philadelphia, United States
Beanie_Mojo
Beanie_Mojo Mar. 17 at 1:36 PM
$IPSC bullish af 🔥💴
0 · Reply
AlertsAndNews
AlertsAndNews Mar. 16 at 10:56 PM
Gappers here in after hours trading $LIDR $ONFO $IPSC $LNAI $JVA I'll try to update later this evening.
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 16 at 8:13 PM
$IPSC
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 16 at 1:37 PM
$IPSC
0 · Reply
Jnutz14
Jnutz14 Mar. 16 at 12:41 PM
$IPSC
0 · Reply
DARKP00L
DARKP00L Mar. 16 at 12:01 PM
$IPSC 07:50 on Mar. 16 2026 iSpecimen Collects 500 Influenza Samples, Showcases Rapid Research Support #tradeideas
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 14 at 12:15 AM
$IPSC
0 · Reply
Lukey63
Lukey63 Mar. 13 at 5:22 PM
$IPSC positive results. Drop on minimal volume.
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 13 at 1:36 PM
$IPSC
0 · Reply
bigtradesgg
bigtradesgg Mar. 13 at 7:44 AM
$CXAI Parabolic Setup, low shortshares available Similar Setup as $IPSC $SKYQ
0 · Reply
Latest News on IPSC
Century Therapeutics to Participate in Upcoming Investor Conferences in March

Feb 25, 2026, 8:00 AM EST - 21 days ago

Century Therapeutics to Participate in Upcoming Investor Conferences in March

IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

Feb 16, 2026, 1:00 PM EST - 4 weeks ago

IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

FATE

Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race

Feb 9, 2026, 11:15 AM EST - 5 weeks ago

Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race

Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference

Nov 25, 2025, 4:01 PM EST - 4 months ago

Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference

Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 13, 2025, 7:30 AM EST - 4 months ago

Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes

Nov 13, 2025, 7:00 AM EST - 4 months ago

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes

Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference

Oct 14, 2025, 4:01 PM EDT - 5 months ago

Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference

Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Aug 22, 2025, 8:00 AM EDT - 7 months ago

Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 14, 2025, 4:01 PM EDT - 7 months ago

Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress

May 28, 2025, 4:01 PM EDT - 10 months ago

Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 15, 2025, 4:01 PM EDT - 10 months ago

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting

Apr 28, 2025, 4:30 PM EDT - 11 months ago

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting

Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Mar 19, 2025, 4:01 PM EDT - 1 year ago

Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 26, 2024, 7:00 AM EST - 1 year ago

Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 5, 2024, 9:05 AM EST - 1 year ago

Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

Century Therapeutics to Present at Guggenheim's Inaugural Healthcare Innovation Conference

Nov 4, 2024, 7:00 AM EST - 1 year ago

Century Therapeutics to Present at Guggenheim's Inaugural Healthcare Innovation Conference

Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer

Sep 26, 2024, 7:00 AM EDT - 1 year ago

Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer

Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

Aug 8, 2024, 7:30 AM EDT - 1 year ago

Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

Century Therapeutics: Cell Therapy Biotech With Expanded Potential Of CNTY-101

Jun 20, 2024, 11:07 AM EDT - 1 year ago

Century Therapeutics: Cell Therapy Biotech With Expanded Potential Of CNTY-101

Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting

Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 9, 2024, 7:30 AM EDT - 2 years ago

Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

Apr 23, 2024, 7:00 AM EDT - 2 years ago

Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics

Apr 11, 2024, 7:00 AM EDT - 2 years ago

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics

Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Apr 8, 2024, 4:05 PM EDT - 2 years ago

Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

Mar 19, 2024, 7:00 AM EDT - 2 years ago

Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates

Mar 14, 2024, 7:30 AM EDT - 2 years ago

Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates

Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Mar 5, 2024, 6:03 PM EST - 2 years ago

Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Feb 1, 2024, 7:00 AM EST - 2 years ago

Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits

Dec 9, 2023, 12:00 PM EST - 2 years ago

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits

Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus

Dec 6, 2023, 7:30 AM EST - 2 years ago

Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus

Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus

Dec 6, 2023, 7:30 AM EST - 2 years ago

Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus

Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference

Nov 21, 2023, 7:00 AM EST - 2 years ago

Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference

Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

Nov 9, 2023, 7:01 AM EST - 2 years ago

Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases

Nov 9, 2023, 7:00 AM EST - 2 years ago

Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases

Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference

Sep 26, 2023, 7:00 AM EDT - 2 years ago

Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference

Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates

Aug 9, 2023, 7:30 AM EDT - 2 years ago

Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates

Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

May 11, 2023, 7:30 AM EDT - 3 years ago

Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

Century Therapeutics to Present at Chardan's 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit

Apr 17, 2023, 7:00 AM EDT - 3 years ago

Century Therapeutics to Present at Chardan's 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit

Century Therapeutics Announces Leadership Changes

Apr 12, 2023, 8:30 AM EDT - 3 years ago

Century Therapeutics Announces Leadership Changes

Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates

Mar 16, 2023, 7:30 AM EDT - 3 years ago

Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates

Century Therapeutics to Present at the AACR Annual Meeting 2023

Mar 15, 2023, 4:01 PM EDT - 3 years ago

Century Therapeutics to Present at the AACR Annual Meeting 2023

Century Therapeutics to Present at Upcoming Investor Conferences

Feb 21, 2023, 7:00 AM EST - 3 years ago

Century Therapeutics to Present at Upcoming Investor Conferences

Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas

Feb 8, 2023, 7:30 AM EST - 3 years ago

Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas

5 Health Care Stocks That Are Diving - And May Rally

Jan 19, 2023, 8:58 AM EST - 3 years ago

5 Health Care Stocks That Are Diving - And May Rally

FATE TECH TAOX

Top 5 Health Care Stocks That May Surge - Graphite Bio (NASDAQ:GRPH), Fate Therapeutics (NASDAQ:FATE)

Jan 10, 2023, 7:33 AM EST - 3 years ago

Top 5 Health Care Stocks That May Surge - Graphite Bio (NASDAQ:GRPH), Fate Therapeutics (NASDAQ:FATE)

FATE THRD VERA

Century Therapeutics closes its Seattle hub amid wider cuts, departure of R&D head

Jan 9, 2023, 9:06 PM EST - 3 years ago

Century Therapeutics closes its Seattle hub amid wider cuts, departure of R&D head

Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026

Jan 5, 2023, 4:01 PM EST - 3 years ago

Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026

Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Jan 4, 2023, 7:00 AM EST - 3 years ago

Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference

Nov 22, 2022, 7:00 AM EST - 3 years ago

Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference

Century Therapeutics Announces Presentation of Preclinical Data at the SITC 37th Annual Meeting and Provides Pipeline Updates

Nov 11, 2022, 7:00 AM EST - 3 years ago

Century Therapeutics Announces Presentation of Preclinical Data at the SITC 37th Annual Meeting and Provides Pipeline Updates

Beanie_Mojo
Beanie_Mojo Mar. 17 at 1:36 PM
$IPSC bullish af 🔥💴
0 · Reply
AlertsAndNews
AlertsAndNews Mar. 16 at 10:56 PM
Gappers here in after hours trading $LIDR $ONFO $IPSC $LNAI $JVA I'll try to update later this evening.
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 16 at 8:13 PM
$IPSC
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 16 at 1:37 PM
$IPSC
0 · Reply
Jnutz14
Jnutz14 Mar. 16 at 12:41 PM
$IPSC
0 · Reply
DARKP00L
DARKP00L Mar. 16 at 12:01 PM
$IPSC 07:50 on Mar. 16 2026 iSpecimen Collects 500 Influenza Samples, Showcases Rapid Research Support #tradeideas
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 14 at 12:15 AM
$IPSC
0 · Reply
Lukey63
Lukey63 Mar. 13 at 5:22 PM
$IPSC positive results. Drop on minimal volume.
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 13 at 1:36 PM
$IPSC
0 · Reply
bigtradesgg
bigtradesgg Mar. 13 at 7:44 AM
$CXAI Parabolic Setup, low shortshares available Similar Setup as $IPSC $SKYQ
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 12 at 3:37 PM
$IPSC market seems tobe red loadup cheapies. .... its going to break high highs.
0 · Reply
Jnutz14
Jnutz14 Mar. 12 at 1:33 PM
$IPSC
0 · Reply
Jnutz14
Jnutz14 Mar. 12 at 1:32 PM
$IPSC
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 12 at 1:31 PM
$IPSC
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 12 at 1:30 PM
$IPSC 😮
0 · Reply
Jnutz14
Jnutz14 Mar. 12 at 1:11 PM
$IPSC Earnings Beat! Now release the trail results and send this thing to the moon!
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 11 at 6:07 PM
$IPSC Green day 🤟🎶. LFG
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 11 at 4:02 PM
$IPSC
0 · Reply
Jnutz14
Jnutz14 Mar. 11 at 12:18 PM
$IPSC
0 · Reply
Invest2live
Invest2live Mar. 10 at 2:39 PM
$IPSC 450% already; congrats 🌿🎈🌿 Checkout $HUMA, $MSFT, $PHR and $TTD for long; highly undervalued
0 · Reply
Beanie_Mojo
Beanie_Mojo Mar. 10 at 12:30 PM
$IPSC breaking 🔨 $2.00 today 💎
1 · Reply
IP192NYC
IP192NYC Mar. 10 at 4:35 AM
$IPSC There are also companies undertaking clinical trials involving iPSC-derived cell therapeutics, including Cynata Therapeutics (and its partner FUJIFILM), Healios K.K. (in collaboration with Sumitomo Dainippon Pharma), Century Therapeutics (who acquired Clade Therapeutics), Ono Pharmaceutical Co., and Fate Therapeutics. Additionally, there are at least 76 companies involved with the commercialization of iPSC-derived cell therapeutics in earlier stage programs. Within the research products realm, the number of market competitors has surged in recent years, although these industry stalwarts continue to defend their positions: Fujifilm Cellular Dynamics, Inc.(USA/Japan), REPROCELL (Japan), Evotec (Europe), Ncardia (Europe), and Axol Bioscience (Europe).
0 · Reply